JP2006519798A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006519798A5 JP2006519798A5 JP2006504466A JP2006504466A JP2006519798A5 JP 2006519798 A5 JP2006519798 A5 JP 2006519798A5 JP 2006504466 A JP2006504466 A JP 2006504466A JP 2006504466 A JP2006504466 A JP 2006504466A JP 2006519798 A5 JP2006519798 A5 JP 2006519798A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- methoxy
- phenyl
- piperidin
- dihydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0305553.0A GB0305553D0 (en) | 2003-03-11 | 2003-03-11 | Compounds |
| PCT/EP2004/001844 WO2004081010A1 (en) | 2003-03-11 | 2004-02-24 | Compounds having activity at 5ht2c receptor and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006519798A JP2006519798A (ja) | 2006-08-31 |
| JP2006519798A5 true JP2006519798A5 (enExample) | 2007-04-12 |
Family
ID=9954549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006504466A Pending JP2006519798A (ja) | 2003-03-11 | 2004-02-24 | ５ＨＴ２ｃ受容体に活性を有する化合物及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20060281786A1 (enExample) |
| EP (1) | EP1603914B1 (enExample) |
| JP (1) | JP2006519798A (enExample) |
| DE (1) | DE602004004378T2 (enExample) |
| ES (1) | ES2276281T3 (enExample) |
| GB (1) | GB0305553D0 (enExample) |
| WO (1) | WO2004081010A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1792629A4 (en) | 2004-08-25 | 2010-08-25 | Takeda Pharmaceutical | MEANS FOR THE PREVENTION / TREATMENT OF STRESS-RELATED HARNINE INCONTINENCE AND PRECAUTIONARY METHOD FOR THIS |
| EP2727585A1 (en) | 2006-05-16 | 2014-05-07 | Takeda Pharmaceutical Company Limited | In-vivo screening method |
| CA2659299A1 (en) | 2006-08-15 | 2008-02-21 | Actelion Pharmaceuticals Ltd | Azetidine compounds |
| EP2216023A4 (en) | 2007-11-15 | 2013-03-13 | Takeda Pharmaceutical | CONDENSED PYRIDINE DERIVATIVE AND ITS USE |
| BRPI0907122B8 (pt) | 2008-01-11 | 2021-05-25 | Albany Molecular Res Inc | compostos de piridoindóis (1-azinona) substituídos, composição farmacêutica compreendendo os referidos compostos, e usos dos mesmos |
| WO2011003012A1 (en) | 2009-07-01 | 2011-01-06 | Albany Molecular Research, Inc. | Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof |
| US8637501B2 (en) | 2009-07-01 | 2014-01-28 | Albany Molecular Research, Inc. | Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine MCH-1 antagonists, methods of making, and use thereof |
| WO2011003007A1 (en) | 2009-07-01 | 2011-01-06 | Albany Molecular Research, Inc. | Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof |
| US9073925B2 (en) | 2009-07-01 | 2015-07-07 | Albany Molecular Research, Inc. | Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof |
| JPWO2011071136A1 (ja) | 2009-12-11 | 2013-04-22 | アステラス製薬株式会社 | 線維筋痛症治療剤 |
| WO2012088038A2 (en) | 2010-12-21 | 2012-06-28 | Albany Molecular Research, Inc. | Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof |
| WO2012088124A2 (en) | 2010-12-21 | 2012-06-28 | Albany Molecular Research, Inc. | Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof |
| NL2017733B1 (en) | 2016-11-07 | 2018-05-23 | Femiscope B V | Vaginal Speculum |
| JPWO2019131902A1 (ja) | 2017-12-27 | 2020-12-10 | 武田薬品工業株式会社 | 腹圧性尿失禁および便失禁の治療薬 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU631131B2 (en) * | 1988-08-02 | 1992-11-19 | Glaxo Group Limited | Lactam derivatives |
| GB8820651D0 (en) * | 1988-09-01 | 1988-10-05 | Glaxo Group Ltd | Medicaments |
| GB8820653D0 (en) * | 1988-09-01 | 1988-10-05 | Glaxo Group Ltd | Medicaments |
| NZ254785A (en) * | 1992-08-20 | 1995-09-26 | Smithkline Beecham Plc | Heterocyclically-condensed indoles and medicaments |
| GB9612885D0 (en) * | 1996-06-20 | 1996-08-21 | Smithkline Beecham Plc | Novel compounds |
| EP1497265B1 (en) * | 2002-04-19 | 2009-02-18 | Glaxo Group Limited | Compounds having affinity at 5ht2c receptor and use thereof in therapy |
-
2003
- 2003-03-11 GB GBGB0305553.0A patent/GB0305553D0/en not_active Ceased
-
2004
- 2004-02-24 US US10/547,988 patent/US20060281786A1/en not_active Abandoned
- 2004-02-24 WO PCT/EP2004/001844 patent/WO2004081010A1/en not_active Ceased
- 2004-02-24 ES ES04713892T patent/ES2276281T3/es not_active Expired - Lifetime
- 2004-02-24 EP EP04713892A patent/EP1603914B1/en not_active Expired - Lifetime
- 2004-02-24 JP JP2006504466A patent/JP2006519798A/ja active Pending
- 2004-02-24 DE DE602004004378T patent/DE602004004378T2/de not_active Expired - Fee Related